Mylan's EpiPen Pricing Scandal - Seven Pillars Institute
Drug Prices: Did Drugmakers Fix Generic Medicines' Prices?
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Drug Pricing Investigation
High prices on Mylan's EpiPen drive EMTs, patients to manual options | Fierce Pharma
States follow feds with accusations of generic price fixing against Mylan, Heritage, others | Fierce Pharma
Cost gap widens between brand-name, generic drugs | MDedge Internal Medicine
Mylan, 17 other generic drugmakers conspired to fix prices, state AGs allege
Expanding the Use of Generic Drugs | ASPE
Mylan's next problem? A shareholder suit demanding damages | Fierce Pharma
Drug Channels: The Big Three Generic Drug Mega-Buyers Drove Double-Digit Deflation in 2018. Stability ahead?
Generic Drug Makers Accused of Illegal Conspiracies over Drug Prices
Authorized-Generic Concerta Medication Update -
States' Lawsuit Accuses 26 Drugmakers of Price Fixing of Generic Drugs
Prescription Drug Costs: CQR
EpiPen CEO to defend lifesaving drug's soaring price in front of lawmakers - The Washington Post
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Drug Channels: Retail Generic Drug Costs Go Up, Up, and Away
Southwest Journal of Pulmonary, Critical Care and Sleep - Editorials
Mylan's EpiPen Pricing Scandal - Seven Pillars Institute
Some generic drug prices soar despite heavy competition | Fierce Pharma
Mylan price hikes on many other drugs eclipsed EpiPen increases
2021 Year-End False Claims Act Update - Gibson Dunn
